Residency · Kansas City, MO
Sponsored by University of Missouri-Kansas City School of Medicine
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.
JAMA oncology · 2022 · 1,677 citations · Ahmed Azzam
Trial of Endovascular Thrombectomy for Large Ischemic Strokes.
The New England journal of medicine · 2023 · 798 citations · Michael Abraham
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.
JAMA · 2023 · 730 citations · Mario Castro
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 914 citations · Ahmed Elkhanany
Cardiovascular-Kidney-Metabolic (CKM) syndrome: A state-of-the-art review.
Current problems in cardiology · 2024 · 274 citations · Gurpreet Johal
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events.
Journal for immunotherapy of cancer · 2021 · 762 citations · Hamzah Abu-Sbeih
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 392 citations · Madhuri Bajaj
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.
Nature medicine · 2021 · 504 citations · Taiyeb Khumri